Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy

Marina Caskey1, Florian Klein1, Michel C Nussenzweig1

  • 1From the Laboratory of Molecular Immunology (M.C., M.C.N.) and the Howard Hughes Medical Institute (M.C.N.), Rockefeller University, New York; and the Laboratory of Experimental Immunology, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, and the German Center for Infection Research, partner site Bonn-Cologne - all in Cologne, Germany (F.K.).

Abstract

No abstract available in PubMed .